Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share

v3.21.2
Earnings Per Share
6 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic earnings per share is calculated using the weighted average number of shares of the Company’s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company’s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants.
As of June 30, 2021 and December 31, 2020, APC held 10,885,732 and 12,323,164 shares of ApolloMed’s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share.
Below is a summary of the earnings per share computations:
Three Months Ended June 30, 2021 2020
Earnings per share – basic
$ 0.29  $ 0.20 
Earnings per share – diluted
$ 0.28  $ 0.19 
Weighted average shares of common stock outstanding – basic
44,165,264  36,071,604 
Weighted average shares of common stock outstanding – diluted
45,828,802  37,285,585 
Six Months Ended June 30, 2021 2020
Earnings per share – basic $ 0.60  $ 0.31 
Earnings per share – diluted $ 0.58  $ 0.30 
Weighted average shares of common stock outstanding – basic 43,255,901  36,040,936 
Weighted average shares of common stock outstanding – diluted 44,746,761  37,296,913 

Below is a summary of the shares included in the diluted earnings per share computations:
Three Months Ended June 30, 2021 2020
Weighted average shares of common stock outstanding – basic 44,165,264  36,071,604 
Stock options 466,104  169,402 
Warrants 992,723  1,041,784 
Restricted stock awards 204,711  2,795 
Weighted average shares of common stock outstanding – diluted 45,828,802  37,285,585 
Six Months Ended June 30, 2021 2020
Weighted average shares of common stock outstanding – basic 43,255,901  36,040,936 
Stock options 409,154  173,299 
Warrants 911,131  1,076,802 
Restricted stock awards 170,575  5,876 
Weighted average shares of common stock outstanding – diluted 44,746,761  37,296,913